Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing central vein stenosis from dialysis catheters in subclavian versus jugular veins

Official title: Central Venous Stenosis Incidence After Right-sided Subclavian and Internal Jugular Vein Catheterization With a Silicone Temporary Hemodialysis Catheter

Run by Skane University Hospital · NCT04871568 · Data updated 2026-11-12

This study is testing whether using temporary dialysis catheters in the subclavian or jugular veins leads to fewer problems with vein narrowing for patients needing hemodialysis.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorSkane University Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Lund)
StatusRecruiting
StartedNovember 15, 2021
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedApril 29, 2026
Trial IDNCT04871568 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who require a temporary central dialysis catheter for at least 7 days.

Probably not a fit

Patients with existing central venous interventions, known right-sided central vein stenosis, or other specific exclusions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the incidence of central vein stenosis (CVS) resulting from temporary hemodialysis catheterization in either the subclavian or jugular veins. It is a multicentric, prospective, randomized, controlled, assessor-blinded trial conducted in three hospitals in southern Sweden. Patients will be randomly assigned to receive a silicone temporary central dialysis catheter (tCDC) in either vein, with follow-up assessments including CT venography and ultrasound to evaluate CVS. The study aims to provide insights into the safety and efficacy of catheter placement techniques.

Why it matters

Potential benefit: If successful, this study could lead to improved catheterization practices that minimize the risk of central vein stenosis for dialysis patients.

How similar studies have gone: Previous studies have indicated varying results regarding the incidence of CVS with different catheter placements, making this approach both relevant and necessary for further investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (18 years of age or older).
* In need of a tCDC with an expected treatment time of at least 7 days.
* Informed consent.

Exclusion Criteria:

* Intravenous pacemaker or a PICC-line via right-sided central veins in situ.
* Known right-sided CVS.
* AV fistula on the right upper extremity.
* History of central venous vascular interventions including stents, dilatations and more (but not previous central venous catheterization).
* Central venous catheter in the right internal jugular vein or in the right subclavian vein in situ.
* Either the right jugular vein or the right subclavian vein unavailable for catheterization due to, e.g., local skin infection, thrombosis or inability to visualize the vein with ultrasound.
* Known allergy to iodinated contrast agents.
* BMI \>35 kg/m2.
* No study physician available for the catheterization.

Where it's running

  • Skånes universitetssjukhus
    Lund, Sweden
    Recruiting

Study contacts

  • Principal investigator: Ola Borgquist, MD, PhD — Skånes universitetssjukhus
  • Study coordinator: Ola Borgquist, MD, PhD
  • Email: oborgquist@gmail.com
  • Phone: +46704156334

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.